Subscribe
Business

Swiss drug maker Roche posts flat 9-month sales

By Washington Examiner
Published
Add Washington Examiner on Google

GENEVA (AP) — Swiss drugmaker Roche Holding AG has reported flat sales for the first nine months of 2014 but says the results show strong demand for its cancer drugs and emerging new products.

The Basel, Switzerland-based company says group sales were 34.8 billion Swiss francs, nearly unchanged from 34.9 billion francs in the same time period last year. But when measured in constant exchange rates, sales rose 5 percent over the first three quarters of the year.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.